Zhuang Tian

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Pulmonary Arterial Hypertension

Angiotensin Converting Enzyme

Top Venues

Annals of hematology

Journal of clinical pharmacy and therapeutics

The Journal of experimental medicine

Expert review of proteomics

This page only lists publications with an associated author ORCID identifier.

Publications

Miao-Yan Zhang, Jian Li, Yi-Ning Wang, Zhuang Tian, Lu Zhang
Unicentric Castleman's disease presenting as amyloid A cardiac amyloidosis: a case report. Annals of hematology (2023)
Shan He, XinYue He, RuoKai Pan, LuRong Pan, Xiaoying Lv, YuTong Jin, Yue Fan, YuTong Wang, Zhuang Tian, ShuYang Zhang
Data-independent acquisition mass spectrometry reveals comprehensive plasma protein profiles in the natural history of patients with hereditary transthyretin amyloidosis (ATTRv). Expert review of proteomics (2023)
Xinyue He, Zhuang Tian, Hongzhi Guan, Shuyang Zhang
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China. Orphanet journal of rare diseases 17 (1) (2022)
Yang Zhang, Yicong Ye, Xiaoqiang Tang, Hui Wang, Toshiko Tanaka, Ran Tian, Xufei Yang, Chen Li, Ying Xiao, Yue-Shen Sun, Ye Jin, Haiyu Pang, Tian Du, Honghong Liu, Lihong Sun, Shuo Xiao, Ruijia Dong, Luigi Ferruci, Zhuang Tian, Shu-Yang Zhang
CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure. The Journal of experimental medicine 219 (8) (2022)
Qinhua Zhao, Na Guo, Jun Chen, Daniel Parks, Zhuang Tian
Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta-analysis. Journal of clinical pharmacy and therapeutics (2021)
Zhuang Tian, Xin Jiang, Zhi-Cheng Jing
How should a physician approach the pharmacological management of chronic thromboembolic pulmonary hypertension? Expert opinion on pharmacotherapy 22 (5) (2020)